AP resection

(redirected from Abdominoperineal excision)

AP resection

A draconian procedure for adenocarcinoma affecting the distal one-third of the rectum, a site which is too low anatomically to salvage sphincter function. AP resections remove the anus, rectum, part of the sigmoid colon, and regional lymph nodes via incisions in the abdomen and perineum. The remaining sigmoid colon is brought out as a permanent colostomy on the abdominal flank.
Mentioned in ?
References in periodicals archive ?
The circumferential resection margin positivity rate is about 5% or less for low anterior resections with TME, whereas it is between 10% and 25% for abdominoperineal excision of the rectum.
Extralevator abdominoperineal excision (ELAPE) has been shown to lead to fewer episodes of bowel perforation and fewer positive circumferential resection margins (CRMs) when compared with conventional abdominoperineal excision (APE) because it achieves a specimen of a more cylindrical shape.[1],[2],[3],[4],[5],[6] Recently, the occurrence and implications of perineal symptoms following ELAPE have been gradually realized; they occur partly because of the wider excision and the presence of more tissue around low rectal tumors when compared with conventional APE.
West NP, Anderin C, Smith KJ, Holm T, Quirke P; European Extralevator Abdominoperineal Excision Study Group, et al.
Abdominoperineal excision (APE) was the standard of care for anal canal squamous cell carcinoma before the introduction of radiotherapy with induction chemotherapy.
Branagan et al., "Comparative quality of life in patients following abdominoperineal excision and low anterior resection for low rectal cancer," Diseases of the Colon & Rectum, vol.
Burt et al., "The use of a negative pressure wound management system in perineal wound closure after extralevator abdominoperineal excision (ELAPE) for low rectal cancer," Techniques in Coloproctology, vol.
Forman, "Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene?" Gut, vol.
Abdominoperineal excision (APE) is a surgical treatment used to treat cancer of the lower third of the rectum or anus where sphincter-preserving surgery (anterior resection (AR) with anastomosis) is not possible.
A systematic review of cancer related patient outcomes after anterior resection and abdominoperineal excision for rectal cancer in the total mesorectal excision era.
Background: When compared with conventional abdominoperineal resection (APR), extralevator abdominoperineal excision (ELAPE) has been demonstrated to reduce the risk of local recurrence for the treatment of locally advanced low rectal cancer.